Fecal transplant and diet change for Crohn's disease
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether a fecal transplant (putting healthy bacteria into your gut) combined with dietary changes can help control active Crohn's disease. It is for people who need stronger treatments or have stopped responding to their current therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have active Crohn's disease and your doctor agrees a fecal transplant is safe for you.
- You are between 18 and 75 years old.
- You are a candidate for advanced therapy (steroids haven't worked, or you can't take or failed other drugs), or you've lost response to advanced treatments.
- Your disease activity score is high enough (CDAI over 150 or certain endoscopic findings).
- You do not have a narrowed or blocked intestine, fistulas, active infections, or serious health problems like heart, liver, or kidney disease.
- You have not had surgery for Crohn's and are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether transferring healthy gut bacteria (a fecal microbiome transplant) can help children with repeated or moderate-to-severe C. difficile infection. It focuses on changing gut bacteria to reduce ongoing infection and symptoms.
This study tests whether a combination of fecal transplant (transferring healthy bacteria from a donor) and dietary changes can help control disease activity in people newly diagnosed with Crohn's. It is for those with mild to moderate symptoms who have not yet taken any Crohn's medications.
This trial tests if a fecal transplant combined with dietary changes can help control symptoms in people with active ulcerative colitis who haven't responded well to standard treatments or advanced therapies.
This study tests whether a combination of fecal transplant (transferring healthy stool into your gut) and dietary changes can help control inflammation in people recently diagnosed with active ulcerative colitis. It may offer a new treatment option before starting stronger medications.
This Phase 1/2 study tests whether a fecal microbiome transplant (FMT) can reduce active inflammation in people with Crohn’s disease. It’s designed for people who currently have signs of active bowel inflammation and can attend regular procedure visits.
This study tests whether a standardized stool-based treatment (fecal microbiota transplantation) can help people with Crohn’s disease. You may qualify if your Crohn’s diagnosis has been stable and you’re willing to receive the fecal transplant.
Hear when a new Crohn’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.